Falnidamol
Falnidamol (BIBX 1382) is a pyrimido-pyrimidine-based, orally bioavailable small molecule that potently and selectively inhibits EGFR tyrosine kinase (IC50=3 nM) . It exhibits over 1000-fold selectivity against ErbB2 and is used in cancer research for its anti-proliferative effects in both cellular and animal models of EGFR-driven tumors.
Product Specifications
CAS Number
196612-93-8
Product Name Alternative
EGFR, Falnidamol, BIBX 1382, BIBX1382, BIBX-1382
Field of Research
Cardiovascular Research, Signal Transduction
Purity
96.46% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2.58 mM) ; DMSO:28.8 mg/mL (74.26 mM)
Smiles
CN1CCC (CC1) Nc1ncc2ncnc (Nc3ccc (F) c (Cl) c3) c2n1
Molecular Formula
C18H19ClFN7
Molecular Weight
387.84
Storage Conditions
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
PHKG1 Protein, Human, Recombinant (GST Tag)
PCSK1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)